Deferred Income Tax Expense (Benefit) of IDEXX LABORATORIES INC /DE from 31 Mar 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
IDEXX LABORATORIES INC /DE annual and quarterly Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2010 to 31 Dec 2024.
  • IDEXX LABORATORIES INC /DE Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $2,571,000, a 32% increase year-over-year.
  • IDEXX LABORATORIES INC /DE annual Deferred Income Tax Expense (Benefit) for 2024 was $24,194,000, a 50% increase from 2023.
  • IDEXX LABORATORIES INC /DE annual Deferred Income Tax Expense (Benefit) for 2023 was $48,306,000, a 38% decline from 2022.
  • IDEXX LABORATORIES INC /DE annual Deferred Income Tax Expense (Benefit) for 2022 was $34,883,000, a 915% decline from 2021.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $24,194,000 +$24,112,000 +50% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
2023 $48,306,000 -$13,423,000 -38% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
2022 $34,883,000 -$31,447,000 -915% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $3,436,000 +$33,278,000 +91% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $36,714,000 -$42,740,000 -709% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
2019 $6,026,000 +$4,891,000 +431% 01 Jan 2019 31 Dec 2019 10-K 16 Feb 2022 2021 FY
2018 $1,135,000 +$9,051,000 01 Jan 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
2017 $7,916,000 -$28,524,000 -138% 01 Jan 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
2016 $20,608,000 +$15,465,000 +301% 01 Jan 2016 31 Dec 2016 10-K 15 Feb 2019 2018 FY
2015 $5,143,000 +$4,313,000 +520% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
2014 $830,000 -$1,243,000 -60% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $2,073,000 +$4,043,000 01 Jan 2013 31 Dec 2013 10-K 17 Feb 2016 2015 FY
2012 $1,970,000 -$7,966,000 -133% 01 Jan 2012 31 Dec 2012 10-K 17 Feb 2015 2014 FY
2011 $5,996,000 +$6,904,000 01 Jan 2011 31 Dec 2011 10-K 18 Feb 2014 2013 FY
2010 $908,000 01 Jan 2010 31 Dec 2010 10-K 19 Feb 2013 2012 FY

IDEXX LABORATORIES INC /DE Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $2,571,000 +$1,186,000 +32% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q1 2023 $3,757,000 +$1,271,000 +25% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q1 2022 $5,028,000 -$10,272,000 -196% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q1 2021 $5,244,000 +$2,391,000 +84% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $2,853,000 -$441,000 -13% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $3,294,000 +$289,000 +9.6% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q1 2018 $3,005,000 +$1,064,000 +55% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q1 2017 $1,941,000 -$579,000 -23% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q1 2016 $2,520,000 +$1,955,000 +346% 01 Jan 2016 31 Mar 2016 10-Q 28 Apr 2017 2017 Q1
Q1 2015 $565,000 +$1,400,000 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016 2016 Q1
Q1 2014 $835,000 -$2,004,000 -171% 01 Jan 2014 31 Mar 2014 10-Q 28 Apr 2015 2015 Q1
Q1 2013 $1,169,000 +$707,000 +153% 01 Jan 2013 31 Mar 2013 10-Q 25 Apr 2014 2014 Q1
Q1 2012 $462,000 -$2,039,000 -82% 01 Jan 2012 31 Mar 2012 10-Q 23 Apr 2013 2013 Q1
Q1 2011 $2,501,000 +$1,732,000 +225% 01 Jan 2011 31 Mar 2011 10-Q 20 Apr 2012 2012 Q1
Q1 2010 $769,000 01 Jan 2010 31 Mar 2010 10-Q 21 Apr 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.